Biocon's Q2 preview highlights strong biosimilar growth, while generics face challenges amid mixed sector performance ahead of November 11 results.

Biocon Biologics recently announced that it would manufacture and supply insulin glargine pens to Civica under a multi-year ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Our Bureau, Bengaluru Monday, October 20, 2025, 15:20 Hrs [IST] Biocon Biologics, a global leader in biosimilars and the world ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Question: I paid so much for my Eliquis this year, will I have to pay that much next year too? Answer: The good news is no, seniors will not pay as much for Eliquis as well as nine other common ...

Gov. Gavin Newsom announced Thursday he is rolling out an effort to lower the price of insulin to $11. CalRx, the state-run program that aims to lower the cost of insulin and other medications, would ...

SACRAMENTO, California — California will start selling low-cost insulin in January, becoming the first state in the nation to bypass Big Pharma with its own supply of the expensive diabetes drug and ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

Prescriptions for the insulin glargine biosimilar Semglee increased after it was granted interchangeable status with its reference product, Lantus. Increases were seen across retail, mail order, and ...

CHAMBERS COUNTY, Texas – After more than a week of testimony and nearly two hours of closing arguments, Sarah Hartsfield has been found guilty of murder after jurors deliberated for about an hour.